OJOG  Vol.5 No.11 , September 2015
The Challenge of Improving IVF Results in Normogonadotrophic (Unexpected) Young Poor Ovarian Responders: The Predictive Value of a Flexible Treatment Protocol Based on the “Biophysical Profile of the Uterus”
ABSTRACT
Objective: To study whether the unexpected poor ovarian responders optimization of uterine receptivity with a flexible controlled ovarian hyper stimulation protocol based on the Biophysical Profile of the Uterus, has an impact on their reproductive performance. Design: Observational Prospective study. Setting(s): i) General hospital-IVF and Infertility Centre; ii) University hospital. Patient(s): 44 normogonadotrophic young women (26 - 38 yrs) with previous “unexpected” poor ovarian response underwent IVF/ICSI treatment on a protocol based on the Biophysical Profile of their uterus (Group A). The same patients were used as controls in a preceded IVF cycle on the conventional stimulation protocol. Intervention(s): None. Main outcome measure(s): Pregnancy, miscarriage and home take baby rates, amount and duration of gonadotropins required, number and quality of embryos resulted, Biophysical Profile of the Uterus score. Result(s). Treatment in Group A in comparison to Group B resulted in significantly larger number of eggs retrieved per patient, and improved fertilization rates and higher number of embryos/ET (p = 0.011, 0.010 and 0.034 respectively). Group A also demonstrated a trend for higher rates of clinical pregnancy (29.5% v.s. 15.9%), viable stage pregnancies ≥ 24 weeks (33.3% v.s. 20%) and home take babies (26.6% v.s. 16%). The amount of gonadotropins used per patient (IU) was similar in the two groups (p = 0.264). Cancellation, implantation and miscarriage rates as well as embryos quality, although superior in the treatment Group A, showed no significant difference. The number of pregnancies achieved in Group A, were directly related with the score in the Biophysical Profile of the Uterus 12 point scale. Conclusion(s): Unexpected Poor Ovarian Responders on the flexible IVF/ICSI protocol (Group A), adjusting the management according to the Biophysical Profile of their uterus (duration of stimulation, day of HCG and day of embryo transfer), had a significantly better performance in comparison to the Group B managed on the conventional protocol in this difficult to manage and so far, rather understudied population.

Cite this paper
Tzafetas, M. , Tantanasis, T. , Zournatzi, V. , Lathouras, K. , Loufopoulos, A. (2015) The Challenge of Improving IVF Results in Normogonadotrophic (Unexpected) Young Poor Ovarian Responders: The Predictive Value of a Flexible Treatment Protocol Based on the “Biophysical Profile of the Uterus”. Open Journal of Obstetrics and Gynecology, 5, 654-664. doi: 10.4236/ojog.2015.511092.
References
[1]   Polyzos, N.P. and Devroey, P. (2011) A Systematic Review of Randomized Trials for the Treatment of Poor Ovarian Responders: Is There Any Light at the End of the tunnel? Fertility and Sterility, 96, 1058-1061.
http://dx.doi.org/10.1016/j.fertnstert.2011.09.048

[2]   Wei, Z., Cheng, X., Li, H., Cao, Y., Cong, L., Zhou, P. and Li, J. (2010) Effects of Prolonging Administration Gonadotropin on Unexpectedly Poor Ovarian Responders Undergoing in Vitro Fertilization. Reproductive Biology and Endocrinology, 8, 26-34.
http://dx.doi.org/10.1186/1477-7827-8-26

[3]   Ferraretti, A.P., La Marca, A., Fauser, B.C., Tarlatzis, B., Nargund, G. and Gianaroli, L. (2011) ESHRE Consensus on the Definition of “Poor Response” to Ovarian Stimulation for in Vitro Fertilization: The Bologna Criteria. Human Reproduction, 26, 1616-1624.
http://dx.doi.org/10.1093/humrep/der092

[4]   The Practice Committee of ASRM, 2012.

[5]   La Marka, A. and Sunkara, S.K. (2014) Individualization of Controlled Ovarian Stimulation in IVF Using Ovarian Reserve Markers: From Theory to Practice. Human Reproduction Update, 20, 124-140.
http://dx.doi.org/10.1093/humupd/dmt037

[6]   Broer, S.L., Dólleman, M., van Disseldorp, J., et al. (2013) Prediction of an Excessive Response in in Vitro Fertilization from Patient Characteristics and Ovarian Reserve Tests and Comparison in Subgroups: An Individual Patient Data Meta-Analysis. Fertility and Sterility, 100, 420-429.
http://dx.doi.org/10.1016/j.fertnstert.2013.04.024

[7]   Kamel, H.M., Amin, A.H. and Al-Adawy, A.R. (2014) Basal Serum Anti-Mullerian Hormone (AMH) Is a Promising Test in Prediction of Occurrence of Pregnancy Rate in Infertile Women Undergoing ICSI Cycles. Clinical Laboratory, 60, 1717-1723.

[8]   Polyzos, N.P., Nelson, S.M., Stoop, D., et al. (2013) Does the Time Interval between Antimüllerian Hormone Serum Sampling and Initiation of Ovarian Stimulation Affect Its Predictive Ability in in Vitro Fertilization-Intracytoplasmic Sperm Injection Cycles with a Gonadotropin-Releasing Hormone Antagonist? A Retrospective Single-Center Study. Fertility and Sterility, 100, 438-444.
http://dx.doi.org/10.1016/j.fertnstert.2013.03.031

[9]   Zeleznik, A.J., Schuler, H.M. and Reichert, L.E. (1981) Gonadotropin-Binding Sites in the rhesus Monkey Ovary: Role of the Vasculature in the Selective Distribution of Human Chorionic Gonadotropin to the Preovulatory Follicle. Endocrinology, 109, 356-362.
http://dx.doi.org/10.1210/endo-109-2-356

[10]   Hernandez, E.R., Hurwitz, A. and Vera, A. (1992) Expression of the Genes Encoding the Insulin-Like Growth Factors and Their Receptors in the Human Ovary. Journal of Clinical Endocrinology & Metabolism, 74, 419-425.

[11]   Haller, K., Salumets, A. and Uibo, R. (2008) Anti-FSH Antibodies Associate with Poor Outcome of Ovarian Stimulation in IVF. Reproductive BioMedicine Online, 16, 350-355.
http://dx.doi.org/10.1016/S1472-6483(10)60595-0

[12]   Lee, D.W., Grasso, P., Dattatreyamurty, B., Deziel, M.R. and Reichert, L.E. (1993) Purification of a High Molecular Weight Follicle-Stimulating Hormone Receptor-Binding Inhibitor from Human Follicular Fluid. The Journal of Clinical Endocrinology and Metabolism, 7, 163-168.

[13]   Papaleo, E., Vanni, V.S., Vigano, P., La Marca, A., Pagliardini, L., Vitrano, R., Zanirato, M., Marsiglio, E., Privitera, L., Cantiani, M. and Recombinant, L.H. (2014) Administration in Subsequent Cycle after ‘‘Unexpected’’ Poor Response to Recombinant FSH Monotherapy. Gynecological Endocrinology, 11, 813-816.
http://dx.doi.org/10.3109/09513590.2014.932342

[14]   Younis, J.S. (2012) The Bologna Criteria for Poor Ovarian Response; Has the Job Been Accomplished? Human Reproduction, 27, 1874-1875.
http://dx.doi.org/10.1093/humrep/des118

[15]   Ferraretti, A.P. and Gianaroli, L. (2014) The Bologna Criteria for the Definition of Poor Ovarian Responders: Is There a Need for Revision? Human Reproduction, 9, 1842-1845.
http://dx.doi.org/10.1093/humrep/deu139

[16]   Bronnstrom, M., Johannesson, L., Bokstrom, L., Kvarnstrom, N., Molne, J., Dahm-Kahler, P., Enskog, A., Milenkovic, M., Ekberg, J., Diaz-Garcia, C., Gabel, M., Hanafy, A., Hagberg, H., Olausson, M. and Nilsson, L. (2015) Livebirth after Uterus Transplantation. The Lancet, 385, 607-616.

[17]   Aplin, J.D. (2009) MUC-1 Glycosylation in Endometrium: Possible Roles of the Apical Glycocalyx at Implantation. Human Reproduction, 14, 17-25.
http://dx.doi.org/10.1093/humrep/14.suppl_2.17

[18]   Ng, E.H., Yeung, W.S. and Ho, P.C. (2009) Endometrial and Sub Endometrial Vascularity Are Significantly Lower in Patients with Endometrial Volume 2.5 ml or Less. Reproductive BioMedicine Online, 18, 262-268.
http://dx.doi.org/10.1016/S1472-6483(10)60264-7

[19]   Sundstrom, P. (1998) Establishment of a Successful Pregnancy Following IVF with an Endometrial Thickness of No More Than 4 mm. Human Reproduction, 13, 1550-1552.
http://dx.doi.org/10.1093/humrep/13.6.1550

[20]   Dallenbach-Hellweg, G. (1981) Histopathology of the Endometrium. Springer-Verlag, Berlin, New York.
http://dx.doi.org/10.1007/978-3-642-96638-5

[21]   Deligdisch, L. (1991) Endometrial Response to Hormonal Therapy. In: Altchek, A. and Deligdisch, L., Eds., The Uterus, Springer-Verlag, Berlin, New York, 102-114.
http://dx.doi.org/10.1007/978-1-4613-9086-2_8

[22]   Goswamy, R.K., Williams, G. and Steptoe, P.C. (1988) Decreased Uterine Perfusion—A Cause of Infertility. Human Reproduction, 3, 955.

[23]   Fleischer, A.C., Kalemeris, G.C., Machin, J.E., Entman, S.S. and Everett Jr., A.E. (1986) Sonographic Depiction of Normal and Abnormal Endometrium with Histopathologic Correlation. Journal of Ultrasound in Medicine, 5, 445-452.

[24]   Kupesic, S., Kurjak, A., Vujisic, S. and Petrovic, Z. (1997) Luteal Phase Defect Comparison between Doppler Velocimetry, Histological and Hormonal Markers. Ultrasound in Obstetrics & Gynecology, 9, 1-8.
http://dx.doi.org/10.1046/j.1469-0705.1997.09020105.x

[25]   Nikas, G., Develioglou, O.H., Toner, J.P. and Jones Jr., H.W. (1999) Endometrial Pinopodes Indicate a Shift in the Window of Receptivity in IVF Cycles. Human Reproduction, 143, 787-792.
http://dx.doi.org/10.1093/humrep/14.3.787

[26]   Pellicer, A., Ballester, M.J., Serrano, M.D., Mir, A., Serra, V., Remohi, J. and Musoles, F.M. (1994) Aetiological Factors Involved in the Low Response to Gonadotrophins in Infertile Women with Normal Basal Serum Follicle Stimulating Hormone Levels. Human Reproduction, 5, 806-811.

[27]   Palatnik, A., Strawn, E., Szabo, A. and Robb, P. (2013) What Is the Optimal Follicular Size before Triggering Ovulation in Trauterine Insemination Cycles with Clomiphene Citrate or Letrozole? An Analysis of 988 Cycles. Fertility and Sterility, 100, 341-348.

[28]   Battaglia, C., Larocca, E., Lanzanni, A., Valentini, M. and Genazzani, A.R. (1990) Doppler Ultrasound Studies of the Uterine Arteries in Spontaneous and IVF Stimulated Ovarian Cycles. Gynecological Endocrinology, 4, 245-250.
http://dx.doi.org/10.3109/09513599009024978

[29]   Zaidi, J., Rudiger, P., Shaker, A., Kyei Mensah, A., Stuart, C. and Tan, S.L. (1996) Assessment of Uterine Artery Blood Flow on the Day of HCG Administration by Transvaginal Color. Doppler Ultrasound in an in Vitro Fertilization Program. Fertility and Sterility, 2, 377-381.

[30]   Cassiatore, B., Simberg, N., Fusato, P. and Tiitinen, A. (1996) Transvaginal Doppler Study of Uterine Artery Blood Flow in Vitro Fertilization—Embryo Transfer Cycles. Fertility and Sterility, 66, 130-134.

[31]   Edi-Osagie, E.C.O., Seif, M.W. and Alpin, J.D. (2004) Characterizing the Endometrium in Unexplained and Tubal Factor Infertility: A Multiparametric Investigation. Fertility and Sterility, 82, 1379-1389.
http://dx.doi.org/10.1016/j.fertnstert.2004.04.046

[32]   Ozturk, O., Bhattacharya, S., Saridogan, E., Jauniaux, E. and Templeton, A. (2004) Role of Utero-Ovarian Vascular Impedance: Predictor of on Going Pregnancy in an IVF—Embryo Transfer Programme. Reproductive BioMedicine Online, 9, 299-305.
http://dx.doi.org/10.1016/S1472-6483(10)62145-1

[33]   Schild, R.L., Holthaus, S., d’Alquen, J., et al. (2000) Measurement of Endometrial Blood Flow Using 3D Ultrasound Is of Prognostic Value with Regard to the Implantation Rates after IVF. Human Reproduction, 15, 89-94.
http://dx.doi.org/10.1093/humrep/15.1.89

[34]   Wu, H.M., Chiang, C.H., Huang, H.Y., Chao, A.S., Wuang, H.S. and Soong, Y.K. (2002) Detection of Subendometrial Vascularization Flow Index by Three—Dimentional Ultrasound May Be Useful in Predicting the Pregnancy Rate for Patients Undergoing in Vitro Fertilization—Embryo Transfer. Fertility and Sterility, 79, 5007-5011.

[35]   Wang, L., Qiao, J., Zhen, X. and Liu, Z. (2010) Role of Endometrial Blood Flow Assessment with Color Doppler Energy in Predicting Pregnancy Outcome of IVF-Et Cycles. Reproductive Biology and Endocrinology, 8, 122-126.
http://dx.doi.org/10.1186/1477-7827-8-122

[36]   Singh, N., Bahadur, A., Mittal, S., Malhotra, N. and Bhatt, A. (2011) Predictive Calue of Endometrial Thickness, Pattern and Sub-Endometrail Blood Flowson the Day of HCG by 2D Doppler in in Vitro Fertilization Cycles: A Prospective Clinical Study from a Tertiary Cae Unit. Journal of Human Reproductive Sciences, 1, 29-33.

[37]   Shrestha, S.M., Costello, M.F., Sjoblom, P., et al. (2004) The Blood Flow in the Follicular Wall Is a Good Prognostic Index for a Positive Outcome But Not That in the Endometrium. Biological Journals and Abbreviations, 21, 387-395.
http://dx.doi.org/10.1007/s10815-004-7526-7

[38]   Yu, N.G., et al. (2006) Single Endometrial and Sub-Endometrial Blood Flow Measurement Is Lacking Prognostic Value. Human Reproduction, 21, 164-170.

[39]   Edwards, R.G. and Brody, S.A. (1995) Natural Cycle and Ovarian Stimulation in Assisted Conception. WB Saunders, Philadelphia, 233-284.

[40]   Steer, C.V., Mills, C.L., Tan, S.L., Campbe, S. and Edwards, R.G. (1992) The Cumulative Embryo Score: A Predictive Embryo Scoring Technique to Select the Optimal Number of Embryos to Transfer in an in-Vitro Fertilization and Embryo Transfer Programme. Human Reproduction, 7, 117-119.

[41]   Fanchin, R. (2001) Assessing Uterine Receptivity in 2001: Ultrasonographic Glances at the New Millenium. Annals of the New York Academy of Sciences, 973, 185-202.
http://dx.doi.org/10.1111/j.1749-6632.2001.tb03802.x

[42]   Crosignani, P., Ragni, G., Lombroso, G., Scardirelli, C., de Laurentis, L., Caccamo, A., et al. (1989) IVF: Induction of Ovulation in Poor Responders. Journal of Steroid Biochemistry, 32, 171-173.
http://dx.doi.org/10.1016/0022-4731(89)90160-X

[43]   Hofmann, G., Toner, J., Muasher, S. and Jones, G. (1989) High-Dose Follicle—Stimulating Hormone (FSH) Ovarian Stimulation in Low—Responder Patients for in Vitro Fertilization. Journal of in Vitro Fertilization and Embryo Transfer, 6, 285-289.
http://dx.doi.org/10.1007/BF01139183

[44]   Haas, J., Zilberberg, E., Machtinger, R., Kedem, A., Hourvitz, A. and Olvieto, R. (2015) Do Poor Responders Benefit from Increasing the Daily Gonadotropin Dose during Controlled Ovarian Hyperstimulation for IVF? Gynecological Endocrinology, 1, 79-82.
http://dx.doi.org/10.3109/09513590.2014.959919

[45]   Ben-Rafael, Z., Benadiva, C., Ansmanas, M., Barder, B., Blasco, L., Flickinger, G., et al. (1987) Dose of human menopausal gonadotropin influences the outcome of an in vitro fertilization program. Fertility and Sterility, 48, 964-968.

[46]   Surrey, E.S. and Schoolcraft, W.B. (2000) Evaluating Strategies for Improving Ovarian Response of the Poor Responder Undergoing Assisted Reproductive Techniques. Fertility and Sterility, 4, 667-676.
http://dx.doi.org/10.1016/S0015-0282(99)00630-5

[47]   Tarlatzis, B.C., Zepiridis, L., Grimbizis, G. and Bontis, J. (2003) Clinical Management of Low Ovarian Response to Stimulation for IVF: A Systematic Review. Human Reproduction Update, 9, 61-76.
http://dx.doi.org/10.1093/humupd/dmg007

[48]   Maheshwari, A., Stofberg, L. and Bhattacharya, S. (2007) Effect of Overweight and Obesity on Assisted Reproductive Technology—A Systematic Review. Human Reproduction Update, 13, 433-444.
http://dx.doi.org/10.1093/humupd/dmm017

[49]   Simoni, M., Nieschlag, E. and Gromoll, J. (2002) Isoforms and Single Nucleotide Polymorphisms of the FSH Receptor Gene: Implications for Human Reproduction. Human Reproduction Update, 8, 413-421.
http://dx.doi.org/10.1093/humupd/8.5.413

[50]   Jirge, P.R., Cavali, S.M. and Bhomkar, D.A. (2014) Impact of Dehydroepiandrosterone on Clinical Outcome in Poor Responders: A Pilot Study in Women Undergoing in Citro Fertilization, Using Bologna Criteria. Journal of Human Reproductive Sciences, 7, 175-180.
http://dx.doi.org/10.4103/0974-1208.142477

[51]   Vlahos, N., Papalouka, M., Triantafyllidou, O., Vlahos, A., Grimbizis, G., Creatsas, G. and Zikopoulos, K. (2015) Dehydroepiandrosterone Administration before IVF in Poor Responders: A Prospective Cohort Study. Reproductive BioMedicine Online, 2, 191-196.
http://dx.doi.org/10.1016/j.rbmo.2014.10.005

[52]   Kolibianakis, E.M., Venetis, C.A., and Tarlatzis, B.C. (2011) DHEA Administration in Poor Responders. Human Reproduction, 26, 730-731.
http://dx.doi.org/10.1093/humrep/deq397

[53]   Yeung, T.W., Chai, J., Li, R.H., Lee, V.C., Ho, P.C. and Ng, E.H. (2014) A Randomized, Controlled, Pilot Trial on the Effect of Dehydroepiandrosterone on Ovarian Response Markers, Ovarian Response and in Vitro Fertilization Outcomes in Poor Responders. Fertility and Sterility, 1, 108-115.
http://dx.doi.org/10.1016/j.fertnstert.2014.03.044

[54]   Hsu, C.J. (1987) Concomitant Effects of Growth Hormone on Secretion of Insulin-Like Growth Factor I and Progesterone by Cultured Porcine Granulose Cells. Endocrinology, 121, 1343-1348.
http://dx.doi.org/10.1210/endo-121-4-1343

[55]   Kolibianakis, E.M., Venetis, C.A., Diedrich, K., Tarlatzis, B.C. and Griesinger, G. (2009) Adition of Growth Hormone to Gonadotrophins in Ovarian Stimulation of Poor Responders Treated by in-Vitro Fertilization: A Systematic Review and Meta-Analysis. Human Reproduction Update, 6, 613-622.
http://dx.doi.org/10.1093/humupd/dmp026

[56]   Zech, M., Baldauf, S., Comploj, G., Murtinger, M., Spitzer, M., Hradecky, L., Ajavi, R., Schuff, M. and Zech, H. (2015) Ovarian Stimulation in ART-Unwinding Pressing Issues. Minerva Ginecologica, 67, 127-147.

[57]   Fan, W., Li, S., Chen, Q., Huang, Z., Ma, Q. and Wang, Y. (2013) Recombinant Luteinizing Hormone Supplementation in Poor Responders Undergoing IVF: A Systematic Review and Meta–Analysis. Gynecological Endocrinology, 4, 278-284.
http://dx.doi.org/10.3109/09513590.2012.743016

 
 
Top